Gujarat Themis Biosyn is at narrow range patternConsolidation with inner triangle
pattern in very narrow range
14.75INR
579.69 MINR
1.49 BINR
19.59 M
About GUJARAT THEMIS BIOSYN LTD.
Sector
CEO
Tapas B. Guhathakurata
Headquarters
Mumbai
Website
Employees (FY)
109
Founded
1981
ISIN
INE942C01045
FIGI
BBG000CS5QV7
Gujarat Themis Biosyn Ltd. operates as a pharmaceutical company. The firm engages in the manufacture of drugs. Its products include Rifamycin and Lovastatin. The company was founded on December 11, 1981 and is headquartered in Mumbai, India.
Breakout Stock with strong fundamentalStock Name : - Gujrat Themis Biosyn Ltd.
Stock has given a breakout on weekly Time frame.
Strong Uptrend Seen ON Chart.
Company has delivered good profit growth of 71.8% CAGR over last 5 years.
Debt to Equity Ratio - 0.00
buy above 285, target openIf one is going to invest in pharma then y not consider a stock which is having good fundamental along with highest ROE(77%) in the sector. iolcp comes 2nd (56%)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GUJTHEM is 385.80 INR — it has increased by 0.72% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GUJARAT THEMIS BIOSYN LTD. stocks are traded under the ticker GUJTHEM.
GUJARAT THEMIS BIOSYN LTD. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
GUJTHEM stock is 3.89% volatile and has beta coefficient of 0.73. Check out the list of the most volatile stocks — is GUJARAT THEMIS BIOSYN LTD. there?
Yes, you can track GUJARAT THEMIS BIOSYN LTD. financials in yearly and quarterly reports right on TradingView.
GUJTHEM stock has fallen by 3.07% compared to the previous week, the month change is a 4.27% rise, over the last year GUJARAT THEMIS BIOSYN LTD. has showed a 159.00% increase.
GUJTHEM net income for the last quarter is 130.13 M INR, while the quarter before that showed 125.43 M INR of net income which accounts for 3.74% change. Track more GUJARAT THEMIS BIOSYN LTD. financial stats to get the full picture.
Today GUJARAT THEMIS BIOSYN LTD. has the market capitalization of 27.83 B, it has increased by 4.08% over the last week.
GUJARAT THEMIS BIOSYN LTD. dividend yield was 0.79% in 2022, and payout ratio reached 13.53%. The year before the numbers were 1.47% and 19.98% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GUJTHEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUJARAT THEMIS BIOSYN LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 109.00 employees. See our rating of the largest employees — is GUJARAT THEMIS BIOSYN LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUJARAT THEMIS BIOSYN LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUJARAT THEMIS BIOSYN LTD. stock shows the buy signal. See more of GUJARAT THEMIS BIOSYN LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GUJARAT THEMIS BIOSYN LTD. EBITDA is 729.99 M INR, and current EBITDA margin is 50.58%. See more stats in GUJARAT THEMIS BIOSYN LTD. financial statements.